cryoICE® cryoablation probe
Superior Science, Innovative Ergonomics
Further improving upon the existing cryo platform, the second generation cryoICE® cryoablation probe offers several NEW features that improve ergonomic function while still delivering best in class performance.
Greatest work capacity in the cardiac cryoablation market.
Gas: N2O has a higher heat absorption capacity than argon.1
Probe Material: 12x higher thermal conductivity than competitors' products.2
Probe Surface: Smooth probe vs. corrugated reduces gaps where ice formation hinders thermal conductivity.
Faster at achieving lethal temperatures and maintains that temperature along probe length more consistently.
Active Feedback: Thermocouple measures temperature at probe/tissue interface.
Active defrost feature allows probe to be removed from surface and keep tissue in frozen state.
"Slow thawing of the frozen tissue is a prime destructive factor and is a more important mechanism of cell death in cryosurgery than is rapid cooling. The rate of thawing should be as slow as practical, and is best done by allowing the tissues to thaw with no assistance by heating. Rapid thawing increases the chance of cell survival, which has long been known in the treatment of frostbite."3 - John G. Baust, PhD
The cryoICE cryoablation probe is intended for use in the cryosurgical treatment of cardiac arrhythmias. For additional information, see the summary of the FDA's 510(k) clearance.
1. Lemmon, E.W. “REFPROP, Reference Thermodynamic and Transport Properties.” NIST Standard Reference Database 23, Version 8.0. NIST, 2007. Print.
2. CRC Handbook of Chemistry and Physics, David R. Lide, Ed. 79th Edition, CRC Press, Boca Raton, FL, 1998.
3. Baust, J.G. and Gage, A.A. (2005), The molecular basis of cryosurgery. BJU International, 95:1187-1191. doi: 10.1111/j.1464-410X.2005.05502.x